72 Investment Holdings, LLC — 13F Holdings & Portfolio
CIK 1832749 · latest 13F-HR filed 2026-08-14
72 Investment Holdings, LLC manages $50.0M in 13F-reported U.S. long-equity assets across 5 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are PRAX (44.18%), ANRO (35.27%), LENZ (11.57%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions, exited 0, added to 2, and trimmed 2.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
STAMFORD, CT 06902
$50.0M
Long-equity book
5
Distinct positions
2026-06-30
Filed 2026-08-14
+0 / −0 / ↑2 / ↓2
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- ALTO NEUROSCIENCE INC$2.6M +17.4%
- KORRO BIO INC$514.9K +16.4%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | PRAXIS PRECISION MEDICINES I | PRAX | 74006W207 | $22.1M | 44.18% | 65,933 | SH |
| 2 | ALTO NEUROSCIENCE INC | ANRO | 02157Q109 | $17.6M | 35.27% | 667,778 | SH |
| 3 | LENZ THERAPEUTICS INC | LENZ | 52635N103 | $5.8M | 11.57% | 1,017,751 | SH |
| 4 | KORRO BIO INC | KRRO | 500946108 | $3.6M | 7.30% | 276,831 | SH |
| 5 | CARIBOU BIOSCIENCES INC | CRBU | 142038108 | $834.4K | 1.67% | 474,067 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $50.0M | 5 | 0000919574-26-005540 |
| 2026-03-31 | 2026-05-15 | $49.6M | 5 | 0000919574-26-003468 |
| 2025-12-31 | 2026-02-17 | $50.6M | 5 | 0000902664-26-001106 |
| 2025-09-30 | 2025-11-14 | $67.9M | 5 | 0000902664-25-005031 |